Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 36 Ovarian Neoplasms 15 Leiomyosarcoma 11 Liposarcoma 10 Neoplasms 6 Sarcoma, Ewing 4 Liposarcoma, Myxoid 4 Sarcoma, Synovial 3 Rhabdomyosarcoma 3 Neoplasm Metastasis 3 Histiocytoma, Malignant Fibrous 3 Solitary Fibrous Tumors 2 Sarcoma, Alveolar Soft Part 2 Prostatic Neoplasms 2 Osteosarcoma 2 Neurofibrosarcoma 2 Mesothelioma, Malignant 2 Malignant mesenchymal tumor 2 Ichthyosis, X-Linked 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2 Fibrosarcoma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Bone Neoplasms 2 Wilms Tumor 1 Uterine Neoplasms 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Specimen Handling 8 Paclitaxel 6 Magnetic Resonance Spectroscopy 6 Nivolumab 5 Carboplatin 5 Biopsy 5 pembrolizumab 3 X-Rays 3 olaparib 2 ceralasertib 2 Taxes 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 pelcitoclax 1 pazopanib 1 pamiparib 1 durvalumab 1 cobimetinib 1 cediranib 1 cabozantinib 1 belinostat 1 atezolizumab 1 apatinib 1 Trabectedin 1 Tissue Banks 1 TIC10 compound 1 Radiation 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02993705 2021-08-25

MITO 26

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Completed

Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡